drugset / Trial / NCT01109121
Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
RandomizedParallel-groupTriple-blindTreatment
Summary
This Phase 2 study will be a multicenter, double-blind, randomized, active-comparator study to evaluate the safety and efficacy of tranilast in combination with allopurinol in patients with hyperuricemia and moderate to severe gout.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-12
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | 400 mg | — |
| Comparator | Allopurinol | Small molecule | 600 mg | — |
| Subject | Tranilast | Small molecule | 300 mg | — |